LE WE PMID CA
Kidney (Chronic renal failure)544Niere (Insuffizienz chronische)

Acidosis (metabolic)

Aldosterone

Anemia (Renal)

Arterial hypertension (BASKET)

Calcification

Cardiorenal syndrome

Cardiovascular risk

Cinacalcet

Creatinine

Diuretic agents (BASKET)

Endothelial cell (Progenitor)

Endothelial dysfunction

Endothelin

Fibrosis

Genome toxicity

Heart (Coronary heart disease BASKET)

Heart (Implanted cardioverter defibrillator)

Hepcidin

HIF1alpha und HIF1 (BASKET)

Homocysteine

IGF1

Kidney (Chronic renal failure)

Kidney (Fibrosis)

Kidney (Glomerulus)

Kidney (Medulla)

Kidney (Mesangial cell)

Kidney (Microcirculation)

Kidney (Pressure natriuresis)

Kidney (Progression of renal disease)

Kidney (Uremic toxin)

Lipoprotein (Dyslipoproteinemia Hyperlipoproteinemia)

Magnesium (Hypomagnesiemia)

NADPH oxidase

Nifedipine

Nitric oxide NO

Nitrosonifedipine

Obesity (BASKET)

Paradontosis

Prolyl hydroxylases

Proteomics

PTH (Hyperparathyreoidism secondary)

RAAS (AngiotensinII)

RAAS (Renin angiotensin system)

Receptor (Mineralcorticoid)

Receptor (PPAR)

Receptor (Pro Renin)

Redox (BASKET)

Regeneration of tissues and other biologic structures

Sarcopenia

Statin

Sympathetic hyperactivity

Uric acid (Hyperuricemia)

Vitamin D

ZONAB

2002  
1
2010  
2
Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing.
[20065899] South Med J 103(2): 140-6 (2010)
2008  
3
The ABCDEs of CKD: a simple approach to early detection and management.
[18791503] South Med J 101(10): 1001-6 (2008)
2004  
4
Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.
[15558924] South Med J 97(10): 969-79 (2004)
1994  
5
Pathophysiology of progressive renal failure.
[7939915] South Med J 87(10): 1028-33 (1994)
2009  
6
Discharging patients from the nephrology clinic to primary care--will they get appropriate monitoring of renal function?
[19376793] QJM 102(6): 425-8 (2009)
2008  
7
Role of chronic hypoxia and hypoxia inducible factor in kidney disease.
[18298921] Chin Med J (Engl) 121(3): 257-64 (2008)
2003  
8
Progression of chronic renal failure.
[12824091] Arch Intern Med 163(12): 1417-29 (2003)
1998  
9
Chronic renal insufficiency: a diagnostic and therapeutic approach.
[9738603] Arch Intern Med 158(16): 1743-52 (1998)
2006  
10
Natural history of elevated creatinine levels.
[17279186] Can Fam Physician 52(10): 1264-5 (2006)
2001  
11
Identifying and slowing progressive chronic renal failure.
[11785282] Can Fam Physician 47(-): 2512-8 (2001)
2000  
12
End-stage renal disease. Timely, appropriate treatment is crucial.
[10751988] Can Fam Physician 46(-): 511-2, 522-4 (2000)
2008  
13
Chronic kidney disease and its complications.
[18486718] Prim Care 35(2): 329-44, vii (2008)
2001  
14
Cardiovascular complications of renal disease.
[11559693] Heart 86(4): 459-66 (2001)
2007  
15
Causes and consequences of chronic kidney disease: implications for managed health care.
[17402808] J Manag Care Pharm 13(3 Suppl): S1-9 (2007)
1980  
16
Nutritional assessment and treatment of chronic renal failure.
[7395779] Am J Clin Nutr 33(7): 1586-97 (1980)
1980  
17
Symposium on nutrition in renal disease. Proceedings of the Second International Congress on Nutrition in Renal Disease; June 13--15, 1979, Bologna, Italy.
[6104917] Am J Clin Nutr 33(7): 1342-702 (1980)
1997  
18
Abnormal lipid metabolism and renal disorders.
[9163848] Tohoku J Exp Med 181(3): 321-37 (1997)
1992  
19
Preservation of renal function in chronic renal failure.
[1412442] Tohoku J Exp Med 166(1): 165-83 (1992)
2009  
20
Early angiography in patients with chronic kidney disease: a collaborative systematic review.
[19423566] Clin J Am Soc Nephrol 4(6): 1032-43 (2009)
2009  
21
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
[19261819] Clin J Am Soc Nephrol 4(3): 542-51 (2009)
2006  
22
Do we know the correct hemoglobin target for anemic patients with chronic kidney disease?
[17699272] Clin J Am Soc Nephrol 1(4): 678-84 (2006)
2006  
23
Aldosterone antagonism in chronic kidney disease.
[17699271] Clin J Am Soc Nephrol 1(4): 668-77 (2006)
2009  
24
2008  
25
Nitric oxide deficiency in chronic kidney disease.
[17928410] Am J Physiol Renal Physiol 294(1): F1-9 (2008)
1971  
26
Function of the chronically diseased kidney. The adaptive nephron.
[4936137] Circ Res 28(5): Suppl 2:1-13 (1971)
2008  
27
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.
[18417749] Clin J Am Soc Nephrol 3(4): 1185-94 (2008)
2007  
28
The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
[17699494] Clin J Am Soc Nephrol 2(4): 766-85 (2007)
2004  
29
Causes and consequences of increased sympathetic activity in renal disease.
[14981063] Hypertension 43(4): 699-706 (2004)
2003  
30
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
[14604997] Hypertension 42(5): 1050-65 (2003)
1993  
31
Essential hypertension: a renal disease? A review and update of the evidence.
[8478047] Hypertension 21(3): 380-90 (1993)
1980  
32
Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture.
[6995288] Hypertension 2(4): 444-64 (1980)
2009  
33
Timing of onset of CKD-related metabolic complications.
[19005010] J Am Soc Nephrol 20(1): 164-71 (2009)
2008  
34
Staging of chronic kidney disease: time for a course correction.
[18385419] J Am Soc Nephrol 19(5): 844-6 (2008)
2007  
35
Frontiers in nephrology: early atherosclerosis--a view beyond the lumen.
[17928505] J Am Soc Nephrol 18(11): 2836-42 (2007)
2007  
36
Frontiers in nephrology: viewing the kidney through the heart--endothelial dysfunction in chronic kidney disease.
[17928504] J Am Soc Nephrol 18(11): 2833-5 (2007)
2006  
37
Chronic kidney disease and mortality risk: a systematic review.
[16738019] J Am Soc Nephrol 17(7): 2034-47 (2006)
2004  
38
Sympathetic hyperactivity in chronic renal failure: a wake-up call.
[14978154] J Am Soc Nephrol 15(3): 524-37 (2004)
1991  
39
Cardiovascular complications in renal failure.
[1777585] J Am Soc Nephrol 2(6): 1053-62 (1991)
1991  
40
The natural history of myocardial disease in dialysis patients.
[1832984] J Am Soc Nephrol 2(1): 2-12 (1991)
2001  
41
Coronary artery disease in uremia: Etiology, diagnosis, and therapy.
[11737581] Kidney Int 60(6): 2059-78 (2001)
1995  
42
Treatment of children with chronic renal failure.
[7752597] Kidney Int 47(3): 951-61 (1995)
2007  
43
Chronic kidney disease: effects on the cardiovascular system.
[17606856] Circulation 116(1): 85-97 (2007)
2008  
44
Diagnosis and management of chronic kidney disease.
[18775206] Mayo Clin Proc 83(9): 1064-9 (2008)
2006  
45
Late referral of patients with chronic kidney disease: no time to waste.
[17120405] Mayo Clin Proc 81(11): 1487-94 (2006)
2006  
46
Early referral for chronic kidney disease: good for those who need it, but who are they?
[17120394] Mayo Clin Proc 81(11): 1420-2 (2006)
1998  
47
2003  
48
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.
[12777562] Pediatrics 111(6 Pt 1): 1416-21 (2003)
2008  
49
Guidelines for the management of chronic kidney disease.
[19015566] CMAJ 179(11): 1154-62 (2008)
2008  
50
Progress and promise in the management of chronic kidney disease.
[19015553] CMAJ 179(11): 1107-8 (2008)
2002  
51
Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.
[11873927] CMAJ 166(4): 473-7 (2002)
1993  
52
Musculoskeletal manifestations of chronic renal insufficiency.
[8460225] Radiographics 13(2): 357-79 (1993)
2011  
53
The role of statins in chronic kidney disease.
[21791915] Am J Nephrol 34(3): 195-202 (2011)
2010  
54
Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.
[20484892] Am J Nephrol 31(6): 541-50 (2010)
2010  
55
The use of targeted biomarkers for chronic kidney disease.
[21044769] Adv Chronic Kidney Dis 17(6): 469-79 (2010)
2010  
56
Mass spectrometry in chronic kidney disease research.
[21044768] Adv Chronic Kidney Dis 17(6): 455-68 (2010)
2008  
57
Progression from acute kidney injury to chronic kidney disease: a pediatric perspective.
[18565478] Adv Chronic Kidney Dis 15(3): 278-83 (2008)
2010  
58
Review of muscle wasting associated with chronic kidney disease.
[20181807] Am J Clin Nutr 91(4): 1128S-1132S (2010)
2005  
59
Survival advantages of obesity in dialysis patients.
[15755821] Am J Clin Nutr 81(3): 543-54 (2005)
2008  
60
The role of hyperuricemia and gout in kidney and cardiovascular disease.
[18822470] Cleve Clin J Med 75 Suppl 5(-): S13-6 (2008)
2009  
61
Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic.
[19255004] Pediatrics 123(3): 791-6 (2009)
2007  
62
Effects of statins on renal function.
[17976359] Mayo Clin Proc 82(11): 1381-90 (2007)
2002  
63
New insights into diuretic use in patients with chronic renal disease.
[11856788] J Am Soc Nephrol 13(3): 798-805 (2002)
2002  
64
Role of the microvascular endothelium in progressive renal disease.
[11856789] J Am Soc Nephrol 13(3): 806-16 (2002)
2003  
65
Prevention of the development and progression of renal disease.
[12819320] J Am Soc Nephrol 14(7 Suppl 2): S144-7 (2003)
2009  
66
The case for using albuminuria in staging chronic kidney disease.
[19255126] J Am Soc Nephrol 20(3): 465-8 (2009)
2007  
67
Lipoprotein metabolism and lipid management in chronic kidney disease.
[17360943] J Am Soc Nephrol 18(4): 1246-61 (2007)
2007  
68
More on renal disease progression: is interstitial inflammation truly protective?
[17513321] J Am Soc Nephrol 18(6): 1630-2 (2007)
2009  
69
Sympathetic activation in chronic renal failure.
[18799718] J Am Soc Nephrol 20(5): 933-9 (2009)
2009  
70
Metabolic acidosis and progression of chronic kidney disease.
[19696222] J Am Soc Nephrol 20(9): 1869-70 (2009)
2006  
71
Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
[16490741] Nephrol Dial Transplant 21(5): 1161-6 (2006)
2006  
72
Are peroxisome proliferator-activated receptors new therapeutic targets in diabetic and non-diabetic nephropathies?
[16880183] Nephrol Dial Transplant 21(10): 2696-702 (2006)
2006  
73
2004  
74
Sympathetic hyperactivity in chronic kidney disease.
[15069180] Nephrol Dial Transplant 19(6): 1354-7 (2004)
2009  
75
Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF).
[19561347] Nephrol Dial Transplant 24(9): 2615-7 (2009)
2011  
76
Consequences and therapy of the metabolic acidosis of chronic kidney disease.
[20526632] Pediatr Nephrol 26(1): 19-28 (2011)
2011  
77
Heat shock proteins in chronic kidney disease.
[21193931] Pediatr Nephrol 26(7): 1031-7 (2011)
2008  
78
Therapeutic strategies to slow chronic kidney disease progression.
[18335252] Pediatr Nephrol 23(5): 705-16 (2008)
2008  
79
Hypertension in children with chronic kidney disease: pathophysiology and management.
[17990006] Pediatr Nephrol 23(3): 363-71 (2008)
2009  
80
End-stage renal disease: in vivo diffusion-tensor imaging of silent white matter damage.
[19528357] Radiology 252(2): 518-25 (2009)
2006  
81
Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla.
[16404134] J Pharmacol Sci 100(1): 2-8 (2006)
2006  
82
Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.
[16397374] J Pharmacol Sci 100(1): 9-16 (2006)
2008  
83
Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.
[19057124] J Pharmacol Sci 108(4): 399-405 (2008)
2009  
84
Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers.
[19151533] J Pharmacol Sci 109(1): 1-6 (2009)
2009  
85
Drug discovery for overcoming chronic kidney disease (CKD): the endothelin ET B receptor/nitric oxide system functions as a protective factor in CKD.
[19151534] J Pharmacol Sci 109(1): 7-13 (2009)
2009  
86
Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD.
[19151535] J Pharmacol Sci 109(1): 14-9 (2009)
2009  
87
Drug discovery for overcoming chronic kidney disease (CKD): new therapy for CKD by a (pro)renin-receptor-blocking decoy peptide.
[19151536] J Pharmacol Sci 109(1): 20-3 (2009)
2009  
88
Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD.
[19151537] J Pharmacol Sci 109(1): 24-31 (2009)
2009  
89
Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
[19812050] Europace 11(11): 1469-75 (2009)
2011  
90
Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.
[22039429] PLoS One 6(10): e25920 (2011)
2003  
91
Nephrology: 4. Strategies for the care of adults with chronic kidney disease.
[12796336] CMAJ 168(12): 1553-60 (2003)
2010  
92
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
[20441712] Health Technol Assess 14(21): 1-184 (2010)
2007  
93
Treatment of hypertension in patients with nondiabetic chronic kidney disease.
[17534470] Can J Cardiol 23(7): 595-601 (2007)
2009  
94
Hypertension in dialysis and kidney transplant patients.
[19417862] Can J Cardiol 25(5): 309-14 (2009)
2010  
95
Current status of the measurement of blood hepcidin levels in chronic kidney disease.
[20724518] Clin J Am Soc Nephrol 5(9): 1681-9 (2010)
2010  
96
Survival benefits with vitamin D receptor activation: new insights since 2003.
[20507950] Clin J Am Soc Nephrol 5(9): 1704-9 (2010)
2008  
97
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
[18945995] Clin J Am Soc Nephrol 3(6): 1718-25 (2008)
2008  
98
Improving global outcomes in mineral and bone disorders.
[18988697] Clin J Am Soc Nephrol 3 Suppl 3(-): S127-30 (2008)
2008  
99
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
[18184879] Clin J Am Soc Nephrol 3(2): 505-21 (2008)
2002  
100
Guidelines for initiation of renal replacement therapy: dialysis versus transplantation.
[18209422] Saudi J Kidney Dis Transpl 13(3): 257-65 (2002)
2011  
101
2011  
102
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease.
[21655762] Clinics (Sao Paulo) 66(4): 657-62 (2011)
2010  
103
Genomic damage in endstage renal disease-contribution of uremic toxins.
[22069557] Toxins (Basel) 2(10): 2340-58 (2010)
2011  
104
Can we prolong life of patients with advanced chronic kidney disease: what is the clinical evidence?
[21430610] Pol Arch Med Wewn 121(3): 88-93 (2011)
2009  
105
Dyslipidemia in chronic kidney disease: pathogenesis and intervention.
[19776689] Pol Arch Med Wewn 119(7-8): 487-92 (2009)
2010  
106
Scope and mechanisms of obesity-related renal disease.
[20134323] Curr Opin Nephrol Hypertens 19(3): 227-34 (2010)
2009  
107
Mechanisms for increased cardiovascular disease in chronic kidney dysfunction.
[19374004] Curr Opin Nephrol Hypertens 18(3): 181-8 (2009)
2009  
108
Incidence, management, and outcomes of end-stage renal disease in the elderly.
[19374012] Curr Opin Nephrol Hypertens 18(3): 252-7 (2009)
2009  
109
Uric acid: a novel mediator and marker of risk in chronic kidney disease?
[19654543] Curr Opin Nephrol Hypertens 18(6): 526-30 (2009)
2011  
110
Chronic kidney disease in primary care: an opportunity for generalists.
[21359580] J Gen Intern Med 26(4): 356-8 (2011)
2004  
111
Managing dyslipidemia in chronic kidney disease.
[15482558] J Gen Intern Med 19(10): 1045-52 (2004)
2003  
112
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
[12859163] Ann Intern Med 139(2): 137-47 (2003)
2010  
113
Screening for chronic kidney disease: which strategy?
[20155721] J Nephrol 23(2): 147-55 (2010)
2007  
114
Sympathetic hyperactivity--a hidden enemy in chronic kidney disease patients.
[17556322] Perit Dial Int 27 Suppl 2(-): S293-7 (2007)
2008  
115
Immune dysfunction in dialysis patients--prevention and treatment strategies.
[18552249] Perit Dial Int 28 Suppl 3(-): S161-6 (2008)
2010  
116
Magnesium in chronic kidney disease: challenges and opportunities.
[20090315] Blood Purif 29(3): 280-92 (2010)
2005  
117
Why do dialysis patients develop a heart of stone and bone of china?
[15809503] Blood Purif 23(3): 203-10 (2005)
2010  
118
Overview of chronic kidney disease in children.
[20299869] Curr Opin Pediatr 22(2): 158-60 (2010)
2010  
119
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment.
[20357496] Kidney Blood Press Res 33(2): 100-10 (2010)
2011  
120
Dyslipidemia associated with chronic kidney disease.
[21643500] Open Cardiovasc Med J 5(-): 41-8 (2011)
2009  
121
Causes of dysregulation of lipid metabolism in chronic renal failure.
[20017835] Semin Dial 22(6): 644-51 (2009)
2010  
122
Muscle atrophy in chronic kidney disease results from abnormalities in insulin signaling.
[20797566] J Ren Nutr 20(5 Suppl): S24-8 (2010)
2009  
123
Review article: endothelial progenitor cells in renal disease.
[19444962] Nephrology (Carlton) 14(3): 291-7 (2009)
2008  
124
The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.
[17826224] Growth Horm IGF Res 18(1): 17-25 (2008)
2007  
125
Coronary calcification in patients with end-stage renal disease: a novel endocrine disorder?
[17704043] Hormones (Athens) 6(2): 120-31 (2007)
2011  
126
Controversies in chronic kidney disease staging.
[21611077] Clin Biochem Rev 32(2): 55-9 (2011)
2010  
127
Serum phosphate and mortality in patients with chronic kidney disease.
[20688884] Clin J Am Soc Nephrol 5(12): 2251-7 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Adult Renal Failure - Nutrition


  • Search PubMed and many other databases on the combined search terms

    GG: chronic renal failure

  • Niere (Insuffizienz chronische)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia